Answers are grounded in this paper and cite their sources.
New assay method shows accuracy in estimating Repaglinide and Metformin HCL in formulations, suggesting quality control potential.
A new simple, rapid, precise and accurate assay method was developed for simultaneous estimation of Repaglinide and Metformin HCL in pure form and tablet form. The analytes were separated by RP HPLC on a RPPurosnosphere C18 column (5 µm, 4.6mm* 250 mm). The mobile phase was Acetonitrile:methanol (60:40 v/v) at 1.1 ml/min flow rate satisfactorily resolves the tertiary mixture. The UV detector was operated at 214 nm for the determination of all the drugs. Linearity, accuracy and precision were found to be acceptable over the concentration ranges of 2-10 µg/ml for Repaglinide and 10-50 µg/ml for Metformin HCL with a R2 0.9960 and 0.9974 values respectively. The optimized methods proved to be specific, robust and accurate for the quality control of drugs in bulk drug and pharmaceutical formulations.
No takes yet. Share an insight, caveat, or question.
Patil et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: